CLEVELAND, April 13, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY ) today announced that it has reached an agreement to amend the terms of its $50.0 million Term Loan Agreement with CRG LP to expand the borrowing capacity to $65.0 million, along with other updates to the agreement. Modifications to the CRG Term Loan Agreement include: Separately, ViewRay announced its preliminary first quarter 2017 new orders and cash position: "Since receiving FDA clearance at the end of February, we have been pleased with the strong interest in the MRIdian Linac. The expansion of our Term Loan Agreement with CRG provides options to potentially add growth capital to our balance sheet as we continue the launch of our MRIdian Linac," said Chris A. Raanes, president and chief executive officer of ViewRay.